Back to Agenda
Regulatory Affairs: Part 1: The IND – Investigational New Drug
Session Chair(s)
Drusilla Scott, PhD, RAC
Vice President, Regulatory Affairs
Sobi, Inc., United States
Regulatory Affairs: Part 1: The IND – Investigational New Drug
Have an account?